Founder and Partner, HM NanoMed, USA

After earning a Dipl.Ing. in Physics from the Technical University of Vienna, Dr. Hehenberger moved to Sweden and obtained Ph.D. / Dr.Sc. degrees in Quantum Chemistry from Uppsala University. He also spent two years at the University of Florida, Gainesville, as Visiting Associate Professor.


In 1985 he joined IBM in Stockholm where he initiated academic partnerships in computational chemistry and biology, structural engineering, campus networking and high performance computing. Throughout his IBM career which took him to Paris, California (San Jose / Almaden Research), and New York, he has led collaborations with academic and industrial life sciences organizations. The partnerships were based on the joint desire to extend the frontiers of molecular biology, information based medicine, bio-pharmaceutical drug discovery, unstructured data analytics, genomics and nanomedicine. His efforts have been documented in over 40 publications and book chapters. At the end of 2013, Dr. Hehenberger retired from IBM Research and started the HM NanoMed Partnership where he is focused on writing books, co-organizing conferences and pursuing nanomedical and genomic research topics.


His first book “Nanomedicine: Science, Business, and Impact”, published in 2015, covers both the underlying science and the steps needed to take a new biomedical breakthrough all the way from concept to patient benefit.